Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma

British Journal of Ophthalmology

Volumn 89, Issue 1, 2005, Pages 21-25

  Luksch, A ^a   Rainer, G ^a,c   Koyuncu, D ^a   Ehrlich, P ^a   Maca, T ^a   Gschwandtner, M E ^a   Vass, C ^a   Schmetterer, L ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

^c NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NIMODIPINE; PLACEBO;

ADULT; AGED; ARTICLE; CHOROID; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR VISION; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EYE BLOOD FLOW; EYE FUNDUS; GLAUCOMA; HEMODYNAMIC PARAMETERS; HUMAN; INTERFEROMETRY; INTRAOCULAR PRESSURE; LASER DOPPLER FLOWMETRY; OPTIC NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; CALCIUM CHANNEL BLOCKERS; CHOROID; COLOR PERCEPTION; CONTRAST SENSITIVITY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EYE; FUNDUS OCULI; GLAUCOMA, OPEN-ANGLE; HUMANS; MIDDLE AGED; NIMODIPINE; OPTIC DISK; PULSATILE FLOW; RAYNAUD DISEASE; REGIONAL BLOOD FLOW; VASODILATOR AGENTS;

EID: 11144293467     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.037671     Document Type: Article

References (42)

1. Kitazawa Y, Shirai H, Go FJ. The effect of Ca2+-antagonist on visual field in low-tension glaucoma. Graefe's Arch Clin Exp Ophthalmol 1989;227:408-12.
2. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension ana open-angle glaucoma. Am J Ophthalmol 1993;115:608-13.
3. Caspar AZ, Flammer J, Hendrickson P. Influence of nifedipine on the visual fields of patients with optic-nerve head diseases. Eur J Ophthalmol 1994;4:24-8.
4. Bose S, Piltz J, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology 1995;102:1236-41.
5. Sowada A, Kitazawa Y, Yamamoto T, et al. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology 1996;103:283-8.
6. Harris A, Evans DW, Cantor LB, et al. Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma. Am J Ophthalmol 1997;124:296-302.
7. Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma 1998;7:336-42.
8. Netland PA, Grosskreutz CL, Feke GT, et al. Color Doppler analysis of ocular circulation after topical calcium channel blocker. Am J Ophthalmol 1995;119:694-700.
9. Schmidt KG, Mittag TW, Pavlovic S, et al. Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefe's Arch Clin Exp Ophthalmol 1996;234:527-32.
10. Netland PA, Feke GT, Konno S, et al. Optic nerve head circulation after topical calcium channel blocker. J Glaucoma 1996;5:200-6.
11. Cellini M, Possati GL, Caramazza N, et al. The use of flunarizine in the management of low-tension glaucoma: a color Doppler study. Acta Ophthalmol Scand Suppl 1997;224:57-8.
12. Yamamoto T, Niwa Y, Kawakami H, et al. The effect of nilvadipine, a calcium channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma 1998;7:301-5.
13. Tomita G, Niwa Y, Shinohara H, et al. Changes in optic nerve head blood flow and retrobulbar hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int Ophthalmol 1999;23:3-10.
14. Tomita K, Araie M, Tamaki Y, et al. Effects of nilvadipine, a calcium antagonist, on rabbit ocular and optic nerve head circulation in NTG subjects. Invest Ophthalmol Vis Sci 1999b;40:1144-51.
15. Niwa Y, Yamamoto T, Harris A, et al. Relationship between the effect of carbon dioxide inhalation or nilvadipine on orbital blood flow in normal-tension glaucoma. J Glaucoma 2000;9:262-7.
16. Geyer O, Neudorfer M, Kessler A, et al. Effect of oral nifedipine on ocular blood flow in patients with low tension glaucoma. Br J Ophthalmol 1996;80:1060-2.
17. Schocket LS, Grunwald JE, Dupont J. Effect of oral felodipine on ocular circulation. Int Ophthalmol 1999;23:79-84.
18. Keltner JL, Johnson CA, Cello KE, et al. Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol 2003;121:643-50.
19. Kirch W, Ramsch KD, Duhrsen U, et al. Clinical pharmacokinetics of nimodipine in normal and impaired renal function. Int J Clin Pharmacol Res 1984;4:381-4.
20. Riva CE, Marino S, Petrig BL, et al. Laser Doppler flowmetry in the optic nerve. Exp Eye Res 1992;55:499-506.
21. Riva CE, Cranstoun SD, Grunwald JE, et al. Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci 1994;35:4273-81.
22. Bonner R, Nossal R. Principles of laser-Doppler flowmetry in laser-Doppler blood flowmetry. In: Shepard AP, Öberg AP, eds. Vol 107 of Developments in cardiovascular medicine. Boston: Kluwer Academic Publishers, 1990:17-45.
23. Schmetterer L, Lexer F, Unfried C, et al. Topical measurement of fundus pulsations. Opt Eng 1995;34:711-6.
24. Schmetterer L, Dallinger S, Findl O, et al. Noninvasive investigations of the normal ocular circulation in humans. Invest Ophthalmol Vis Sci 1998;39:1210-20.
25. Yu TC, Falcao Reis F, Spileers W, et al. Peripheral color contrast. A new screening test for preglaucomatous visual loss. Invest Ophthalmol Vis Sci 1991;32:2779-89.
26. Falcao Reis FM, O'Donoghue FF, Buceti R, et al. Peripheral contrast sensitivity in glaucoma and ocular Hypertension. Br J Ophthalmol 1990;74:712-14.
27. Ring EFJ, Aarts NJM, Black CM, et al. Raynaud's phenomenon: assessment by thermography. Thermology 1988;3:69-73.
28. Darton K, Black CM. Pyroelectric vidicon thermography and cold challenge quantify the severity of Raynaud's phenomenon. Br J Rheumatol 1991;30:190-5.
29. Black CM, Clark RP, Darton K, et al. A pyroelectric vidicon system for physiological and clinical use. J Physiol 1987;384:6p.
30. Wilson RP, Chanq WJ, Sergott RC, et al. A color Doppler analysis of nifedipine-inducea posterior ocular blood flow changes in open-angle glaucoma. J Glaucoma 1997;6:231-6.
31. Rainer G, Kiss B, Dallinger S, et al. A double-masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma. Br J Clin Pharmacol 2001;52:210-12.
32. van den Kerchoff W, Drewes LR. Transfer of Ca-antagonists nifedipine and nimodipine across the blood brain barrier and their regional distribution in vivo. J Cereb Blood Flow Metab 1985;5:459-60.
33. Horn J, de Haan RJ, Vermeulen M, et al. Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke 2001;32:461-5.
34. Flammer J, Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res 1998;17:267-89.
35. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 1999;43:102-28.
36. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in remodeling. Prog Retin Eye Res 2000;19:297-321.
37. Orgul S, Cioffi GA, Wilson DJ, et al. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci 1996;37:1860-9.
38. Oku H, Sugiyama T, Kojima S, et al. Experimental optic cup enlargement caused by endothelin-1 induced chronic optic nerve head ischemia. Surv Ophthalmol 1999;44:74-84.
39. Haefliger IO, Dettmann E, Liu R, et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol 1999;43:51-8.
40. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001;20:319-49.
41. Strenn K, Matulla B, Wolzt M, et al. Reversal of ET-1 induced ocular hemodynamic effects by low dose nifedipine in man. Clin Pharmacol Ther 1998;63:54-63.
42. Toriu N, Sasaoka M, Shimazawa M, et al. Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1 disturbed circulation in the optic nerve head of rabbits. J Ocul Pharmacol Ther 2001;17:131-49.